Fc variants
    4.
    发明授权

    公开(公告)号:US11198732B2

    公开(公告)日:2021-12-14

    申请号:US16413810

    申请日:2019-05-16

    Applicant: AMGEN INC.

    Abstract: Disclosed are Fc-containing proteins comprising a binding region and a variant Fc region that can elicit one or more immune effector function and/or bind to an Fc receptor more effectively than a similar Fc-containing protein comprising a wild type Fc region. Also disclosed are nucleic acids encoding such Fc-containing proteins, methods for making such proteins, and methods of treatment utilizing such proteins.

    Heterodimeric bispecific antibodies

    公开(公告)号:US11634502B2

    公开(公告)日:2023-04-25

    申请号:US14774320

    申请日:2014-03-13

    Applicant: AMGEN INC.

    Abstract: Provided herein are heterodimeric bispecific antibodies that can mediate cytolysis of a target cell by an immune effector cell, nucleic acids encoding such antibodies, methods of making such antibodies, and methods of using such antibodies. These antibodies comprise two different polypeptide chains, each comprising two immunoglobulin variable regions and, optionally, a half life-extending moiety.

    V-C-FC-V-C ANTIBODY
    10.
    发明申请

    公开(公告)号:US20230055407A1

    公开(公告)日:2023-02-23

    申请号:US17702131

    申请日:2022-03-23

    Applicant: AMGEN INC.

    Abstract: Described herein is a dimeric, bispecific antibody format. Each polypeptide chain of the dimer comprises an immunoglobulin variable region, an immunoglobulin constant region, an Fc polypeptide chain, another immunoglobulin variable region, and another immunoglobulin constant region. Also described are methods of making and using such antibodies.

Patent Agency Ranking